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ular (LV) remodelling after acute MI, but the mechanism of this improvement
has never been assessed. We evaluated the relationship between ECFC levels
and microvascular obstruction (MVO), and the impact of this relation on inf-
arct size and LV remodelling at 6 months as assessed by magnetic resonance
imaging (MRI).
 
Methods:
 
 109 pts<75 years old, admitted with a first MI within 12 hours
of onset of symptoms were enrolled. Peripheral blood samples were drawn to
assess number of ECFC colonies (culture cells). Measurements of infarct size
by MRI were performed at day 5 and 6 months. 
 
Results:
 
 ECFC colonies were detected in 51/109 pts(47.2%) at admission
(ECFC
 
pos
 
 pts). At 5 days, MVO was more frequently observed (63% vs 33%;
p=0.003) and of greater magnitude (7±6% vs 3±5%, p=0.0004) in ECFC
 
neg
 
patients versus ECFC
 
pos
 
 pts respectively. At 6 months, there was a signifi-
cantly greater reduction in infarct size in ECFC
 
pos
 
 pts (–33.7±33.2% vs –
15.1±24.6%, ECFC
 
pos
 
 vs ECFC
 
neg
 
 respectively; p=0.003). This reduction in
infarct size was associated with a significant improvement in LV ejection
fraction and a significant reduction in LV end diastolic and systolic volumes
in ECFC
 
pos
 
 pts. A significant positive correlation was observed among
ECFC
 
pos
 
 pts between MVO at day 5 and infarct size at 6 months (r
 
2
 
=0.58,
p<0.0001), while the number of ECFC colonies was significantly correlated
with the relative change in infarct size at 6 months MRI (r
 
2
 
=0.33, p<0.0001).
 
Conclusion:
 
 The presence of ECFC colonies is associated with a reduced
degree of microvascular obstruction early after myocardial infarction, leading
to reduced infarct size and positive LV remodelling at 6 months and can be
considered as a marker of microvascular integrity in acute MI pts.
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Background:
 
 Free oxygen radicals play an important role in the pathogen-
esis of many diseases including cardiovascular diseases, diabetes, cancer and
aging. Several methods were developed for the direct or indirect measurement
of oxygen free radical and its by-products. Using a new Free Oxygen Radicals
Testing (FORT) the current study is designed first to validate the device and
to investigate the potential relationships between the ROS and clinical or bio-
logical factors in human serum from a population of men with an acute myo-
cardial infarction (AMI).
 
Methods: 
 
We first determined the effect of storage, variability and repro-
ducibility of the FORT test in serum. Then we used the test in 66 patients from
our bio bank of AMI patients.
 
Results: 
 
FORT values vary between 324 and 1198 FORT units, with a
median value of 581 (494-754) FORT units. Among the risk factors, 17%
of patients are diabetic, and 20% are obese. In univariate analysis, the
FORT values seem to be influenced by age (r=0.161, p=0.195), presence of
diabetes (p=0.102), a history of MI (p=0.181), LVEF <40% (p=0.005) and
treatment with -blockers before admission (p=0.053), with ST-Elevation MI
(p=0.058), levels of CRP (r=0.438, p<0.001), the rate of neutrophil
(r=0.203, p=0.107) and peak CK (r=0.274, p=0.028). The analysis of mul-
tiple linear regression showed that CRP (p=0.023), LVEF <40% (p<0.001)
and presence of diabetes (p=0.039) were independent predictors of serum
FORT levels. This statistical model can explain 45% of the variance in the
FORT levels.
 
Conclusions: 
 
The variability of the FORT on serum is minimal and thus
reproducibility can be attained. FORT assay is stable when stored at 20 ˚C for
a couple of months or at 4 ˚C for a few days. FORT correlation with CRP,
LVEF and status of diabetes provides an interesting insight and a good link
between oxidative stress and inflammation in patients with an AMI.
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Background:
 
 Much attention is focused on genetic polymorphisms associ-
ated with coronary artery disease. A candidate gene controversially associated
with risk of coronary events is the kinesin-like protein 6 (KIF6), which is cor-
related with Trp719Arg polymorphism. In acute myocardial infarction (AMI),
endothelial progenitor cells, particularly endothelial colony forming cells
(ECFC) are mobilized from bone marrow and correlated with infarct size
reduction. We investigated whether there was a relationship between presence
of ECFC in AMI at admission and genetic status with regard to the KIF6
Trp719Arg polymorphism (rs20455). 
 
Methods: 
 
Forty five patients aged <75 years old referred for a first STEMI
or non STEMI AMI. Peripheral blood samples were drawn on admission. Iso-
lated peripheral blood mononuclear cells were obtained by Hypaque-Ficoll
density gradient centrifugation and cultured for 4 weeks. Cultured cells were
phenotyped to assess the endothelial origin of ECFC. Genomic DNA was
extracted in all patients and genotyping for allelic variations of KIF6 was per-
formed
 
Results:
 
 Subjects were divided into two groups comparing the (Arg/Arg)
homozygote variants with patients having a Trp allele.  The genotype frequen-
cies were 55%, 31% and 13% for Arg/Arg, Arg/Trp and Trp/Trp respectively.
Between groups, higher levels of TnI, CK and CK-MB wer observed in the
Arg/Arg group (respectively p=0.026, p=0.001 and p=0.031). ECFC were
observed in 33% of patients with AMI. The percentage of patients without
ECFC was significantly higher in the Arg/Arg group (p=0.033). No other sig-
nificant differences were observed between groups.
 
Conclusion:
 
 In this report the Arg/Arg group showed a high number of
ECFC-negative patients. A possible explanation might be the low mobilization
of ECFC from bone marrow in this genotype since KIF6 is involved in cytoki-
nesis. The altered amino acid Trp719Arg could decrease the ECFC released
from the bone marrow in response to chemokines released at the onset of AMI.
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Background:
 
 Myocardial infarction (MI) is one of the major causes of
death all over the world. Because MI frequently occurs suddenly without any
preceding clinical symptoms, the prediction of MI is clinically of great impor-
tance. Angiotensin II is produced primarily by angiotensin I-converting
enzyme (ACE) within atherosclerotic lesions and ACE level correlates with
the severity of vessel wall damage.
 
 
 
We analyzed the evolution with age of the
frequencies of the I/D polymorphism of the ACE, A1166C of the angiotensin
II AT1 receptor (AT1R), and M235T of the angiotensinogen (AGT) gene in a
healthy population and he subsequent comparison to age- and sex-matched
groups of MI patients. 
 
Aim:
 
 To investigate the influence of increasing age on the incidence and
remaining lifetime risk of myocardial infarction in a cohort of older men.
 © Elsevier Masson SAS. All rights reserved.
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Methods:
 
 Polymorphisms of the AGT, ACE (I/D) and AGTR1 (A1166C)
genes in patients and controls were analyzed using allele-specific PCR, and
PCR-rflp. 
 
Results: 
 
A total of 140 healthy subjects and 119 individuals with MI were
divided into two groups < 65 and > 65 years old. The evolution with age
showed that the AGT M allele (P < 0.001) and the ACE I allele (P < 0.05)
frequency decreased with age. The TT genotype frequency increased in
patients with MI > 65 years (OR =3.52; 95% CI; 3.12-5.54). The AA genotype
showed a similar behaviour (OR = 2.9; 95% CI; 1.11-5.6). The DD genotype
increased in the MI > 65 group (OR = 6.66; 95% CI; 2.02-21.9).  Serum ACE
activity was positively associated to age (r=0.38, p=0.000). Patients with DD
genotype > 65 years was significantly higher (119.7 ± 50.8 U/L) than in
patients with DD genotype < 65 years (96.9 ± 31.4 U/L, p=0.039).
 
Conclusions:
 
 The incidence of new cardiovascular disease continued to
increase after age 65 but was most often diagnosed at death. These findings
suggest that people aged 60 and older have a substantial amount of undiag-
nosed disease. We propose that the study of the allele frequency evolution in
an healthy population at different ages is essential to determine risk factors for
MI in case-control studies.
 
252
 
Plakophilin2b is not expressed in the heart : consequences for the
genetic screening of arrhythmogenic right ventricular cardiomyopa-
thy
Estelle Gandjbakhch (1), Véronique Fressard (2), Philippe Charron (1),
Geoffroy Lorin De La Grandmaison (3), Francoise Simon (2), Françoise
Gary (4), Alexia Vite (4), Bernard Hainque (2), Françoise Hidden-Lucet
(1), Michel Komajda (1), Eric Villard (4)
(1) CHU Pitié-Salpêtrière, Département de Cardiologie, Paris, France -
(2) CHU Pitié-Salpêtrière, Service de Biochimie (Unité de Cardiogénéti-
que et Myogénétique), Paris, France - (3) Hôpital Raymond Poincaré,
92380, Garches, Département d’anatomie pathologique et de médecine
légale, Garches, France - (4) Inserm UMRS 956, Paris, France
Background:
 
 Arrhythmogenic right ventricular cardiomyopathy (ARVC)
is an inherited heart disease caused predominantly by heterozygous Plako-
philin-2 (PKP2) mutations. However, few molecular studies have been per-
formed to ascertain their pathogenicity. PKP2 encodes two isoforms, the
longest (PKP2b) including the alternatively spliced exon 6, which is routinely
screened for molecular diagnosis, despite the absence of data on the cardiac
expression of PKP2 isoforms. This study addressed the pathogenicity of exon
6 mutations by focusing on a heterozygous missense p.Arg490Trp variant in
PKP2. 
 
Methods and results:
 
 The p.Arg490Trp variant of PKP2 was identified in two
unrelated ARVC probands and absent from 470 controls. In silico analysis sug-
gests that PKP2 exon 6 is an Alu-derived sequence with very low expression level.
Transcriptional and Western blot analysis confirmed that the exon 6 missing
PKP2a was the only clearly detectable isoform in all heart samples (four controls
and a proband). Moreover, in the proband's heart sample, the variant was not asso-
ciated with aberrant exon 6 splicing or mutant mRNA down-regulation. Finally,
we identified in this proband a heterozygous missense variant (p.Glu2343Lys) in
the desmoplakin gene likely to be the disease-causing mutation.
 
Conclusion:
 
 We demonstrated that only PKP2a is significantly expressed in
the heart. Our results strongly suggest that the p.Arg490Trp mutation and other
variants located in PKP2 exon 6 can not be considered as disease-causing muta-
tions and therefore that PKP2 exon 6 screening is useless in routine ARVC
molecular diagnosis. These results have important consequences for the interpre-
tation of PKP2 mutation screening and subsequent genetic counseling.
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Aim:
 
 A major risk of myocardial ischemia (MI) is the onset of ventricular
fibrillation (VF). Our study evaluated the effect of heart rate reduction (HRR)
induce by ivabradine (IVA), the first selective inhibitor of the pacemaker cur-
rent If, on the risk of onset of VF, and study the possible mechanisms
involved.
 
Methods:
 
 MI was induced in pigs by total occlusion of the anterior inter-
ventricular artery until onset of VF, which was assessed by the VF threshold
(VFT; protocol 1) or the time to onset of VF (TOF; protocol 2), with or
without IVA (0.25mg/kg, i.v.). Electrophysiological, 
hemodynamic parameters and ischemic area were assessed in these two proto-
cols. The impact of IVA was evaluated on: i) ultrastructure of mitochondria
(by electron microscopy) in protocol 1; ii) myocardial energetic status com-
pared with a ß-blocker, propranolol (PROP) in protocol 2; iii) regional myo-
cardial blood flow (RMBF) after 1 min-ischemia followed (without VF) by
reperfusion by positrons emission tomography in protocol 3. 
 
Results:
 
 IVA induced a significant HRR (~25%), increased the VFT and
the TOF. When compare to control, IVA prevented the apparition of mito-
chondrial alterations due to repetitive sequences of MI/VF and reperfusion.
IVA improved the RMBF during reperfusion (after 1 min-occlusion). Also, the
myocardial energetic status evaluated by the concentrations of high energy
phosphates, was in part preserved with IVA. All of these changes were corre-
lated with IVA-induced HRR and were not associated with modifications in
the dP/dtmax.
 
Conclusions:
 
 Our results showed that IVA decreases the risk of the onset
of ischemia-induced VF. This effect can be explained by a preservation of
ultrastructure of mitochondria, an improvement in the RMBF and a better con-
servation of myocardial energetic status. Although further work is needed to
determine the mechanisms underlying these effects, this might give a place of
choice to IVA in the prevention of ischemia-induced VF.
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Aim: 
 
The spontaneously hypertensive rat (SHR) is a model of hypertension
with a Cd36 gene defect, which develops left ventricular hypertrophy (LVH)
between 9 and 12 weeks. At 15 weeks, perfused SHR hearts display a reduced
capacity to use long chain fatty acids (LCFAs) but not carbohydrates (CHOs)
for energy production. In this study, we have further examined LCFA metab-
olism and its potential (dys)regulation in SHR hearts prior to LVH. 
 
Methods:
 
 SHR and control Wistar rat hearts (7 weeks) have been used for:
i) functional and metabolic phenotyping using 
 
ex vivo
 
 perfusion with 
 
13
 
C-
labeled substrates, ii) metabolic gene expression profiling using qPCR, iii)
studies of mechanisms regulating -oxydation (malonyl-CoA, AMPK) and of
the functional impact of the gene mutation in the LCFA transporter Cd36
(western blot, confocal microscopy, qPCR, gene analysis).
 
Results:
 
 Compared to controls, 7-week-old SHR hearts display a lower
contribution of LCFA (i.e. oleate) to oxidation (40%) and triglyceride (2.8-
fold) formation, which is associated with a compensatory increase in CHO
oxidation. These alterations cannot be explained by changes in metabolic gene
expression or common mechanisms regulating -oxidation. Western analyses
demonstrate that compared to controls, cardiac CD36 protein level is lower in
the SHR, while data from confocal microscopy indicate a similar intracellular
localization. Sequence alignment of Cd36 cDNA indicates non-synonymous
